Business · 07/02/2006Updated: 10/17/2026 · 1 min read

FDA Releases Report on First Cycle Review Performance

The Food and Drug Administration (FDA) has made available a report detailing an independent evaluation of the agency's performance in reviewing new drug applications and biological license applications between 2002 and 2004, in response to the Prescription Drug User Fee Amendments of 2002.